Skip to main content
[Preprint]. 2021 Nov 11:2021.11.10.21266139. [Version 1] doi: 10.1101/2021.11.10.21266139

Figure 3:

Figure 3:

Daily new infections assuming no antiviral treatment (Baseline) or assuming coverage of 10–100% of eligible symptomatic individuals in A) Kenya, B) Mexico, C) United States and D) Belgium. For each country, each column represents a different value of AVE (25, 50, 75 or 100% reduction in viral load).